Cancer Medicines IMAT 400 Suppliers Imat 400 is a highly effective medication containing 400 mg of Imatinib, designed to treat certain types of cancers, including chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GISTs). Imat 400 works by inhibiting the action of specific enzymes responsible for cancer cell growth, offering a targeted therapy approach that helps control the progression of these cancers. This powerful medication can be prescribed to patients with CML, GIST, and other conditions associated with abnormal cell growth, providing effective treatment and improving overall survival rates. With Imat 400, patients experience better disease management, reduced tumor size, and improved quality of life. Key Features: Contains 400 mg of Imatinib for effective cancer treatment Targets chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GISTs) Inhibits cancer cell growth by blocking the action of specific enzymes Helps manage cancer progression and improve survival rates Well-tolerated with a focus on targeted therapy If you're looking for a reliable solution for managing CML or GISTs, Imat 400 provides a clinically proven treatment that targets the root cause of abnormal cell growth, offering hope and improved outcomes for cancer patients.